» Articles » PMID: 2888321

Clinical Nonrecognition of Neuroleptic-induced Movement Disorders: a Cautionary Study

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 1987 Sep 1
PMID 2888321
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Extrapyramidal side effects are a major limitation in the use of neuroleptics, and tardive dyskinesia is a special public health problem. Accurate clinical diagnosis of extrapyramidal syndromes is necessary for effective management. The authors compared clinicians' recognition of the major extrapyramidal syndromes in 48 psychotic inpatients with independent blind diagnoses by clinical researchers using standardized ratings. The major finding was a high rate of clinical underrecognition of all major extrapyramidal syndromes, especially tardive dyskinesia. The authors discuss the clinical predictors of nonrecognition of extrapyramidal side effects and recommend improved training in their detection.

Citing Articles

Neurological Perspectives Should Be Integrated Into the Management of Tardive Dyskinesia-Expert Opinions and Proposed Educational Initiatives in Asia.

Bhidayasiri R, Phokaewvarangkul O, Lim T, Pal P, Watanabe H, Cho J J Mov Disord. 2024; 17(3):262-269.

PMID: 38600683 PMC: 11300398. DOI: 10.14802/jmd.24068.


The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis.

Barer Y, Ribalov R, Yaari A, Maor R, Arow Q, Logan J J Clin Psychopharmacol. 2022; 42(5):454-460.

PMID: 36018237 PMC: 9426751. DOI: 10.1097/JCP.0000000000001597.


Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients.

Vaiman E, Shnayder N, Novitsky M, Dobrodeeva V, Goncharova P, Bochanova E Biomedicines. 2021; 9(8).

PMID: 34440083 PMC: 8389582. DOI: 10.3390/biomedicines9080879.


The nature of bradykinesia in schizophrenia treated with antipsychotics.

Caligiuri M, Teulings H, Dean C, Lohr J Psychiatry Res. 2019; 273:537-543.

PMID: 30710809 PMC: 6561794. DOI: 10.1016/j.psychres.2019.01.058.


Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.

Ward K, Citrome L Neurol Ther. 2018; 7(2):233-248.

PMID: 30027457 PMC: 6283785. DOI: 10.1007/s40120-018-0105-0.